Cargando…

Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very u...

Descripción completa

Detalles Bibliográficos
Autores principales: Arinuma, Yoshiyuki, Kikuchi, Hirotoshi, Wada, Tatsuhiko, Nagai, Tatsuo, Tanaka, Sumiaki, Oba, Hiroshi, Hirohata, Shunsei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225739/
https://www.ncbi.nlm.nih.gov/pubmed/25396069
http://dx.doi.org/10.1136/lupus-2014-000050
_version_ 1782343561810804736
author Arinuma, Yoshiyuki
Kikuchi, Hirotoshi
Wada, Tatsuhiko
Nagai, Tatsuo
Tanaka, Sumiaki
Oba, Hiroshi
Hirohata, Shunsei
author_facet Arinuma, Yoshiyuki
Kikuchi, Hirotoshi
Wada, Tatsuhiko
Nagai, Tatsuo
Tanaka, Sumiaki
Oba, Hiroshi
Hirohata, Shunsei
author_sort Arinuma, Yoshiyuki
collection PubMed
description BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very useful tool to detect the various abnormalities. However, the relationship between brain MRI findings and clinical variables has not yet been clarified in patients with diffuse NPSLE. OBJECTIVES: The aim of this study is to investigate the pathogenesis of diffuse NPSLE, by comparing various parameters such as serum autoantibodies and cytokines in cerebrospinal fluid (CSF) with abnormal findings revealed on brain MRIs in patients with diffuse NPSLE. METHODS: Fifty-three patients with diffuse NPSLE admitted to our University Hospital from 1992 to 2012 were exhaustively enrolled in this study. Their medical charts and brain MRI scans were reviewed. The relationship of MRI abnormalities with various parameters was analysed. RESULTS: As many as 25 of 53 patients (47.2%) had abnormal MRI findings. MRI findings improved after treatment in 10 of 17 patients for whom follow-up studies were available. MRI abnormalities were not correlated with age at the onset of diffuse NPSLE. However, the disease duration of SLE was significantly longer in patients with abnormal MRI findings (p=0.0009). MRI abnormalities were not significantly associated with serum autoantibodies. However, there were significant elevations of the CSF protein level (p=0.0106) and the CSF interleukin 6 level (p=0.0225) in patients with abnormal MRI findings. Patients with MRI abnormalities showed significantly higher overall mortality (p=0.0348). CONCLUSIONS: The results revealed that MRI abnormalities in diffuse NPSLE might be heterogeneous with regard to their reversibility. These data also indicate that patients with diffuse NPSLE and MRI abnormalities have more severe inflammation in the central nervous system related to the activity of diffuse NPSLE, as evidenced by poorer prognosis.
format Online
Article
Text
id pubmed-4225739
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42257392014-11-13 Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus Arinuma, Yoshiyuki Kikuchi, Hirotoshi Wada, Tatsuhiko Nagai, Tatsuo Tanaka, Sumiaki Oba, Hiroshi Hirohata, Shunsei Lupus Sci Med Immunology and Inflammation BACKGROUND: Manifestations in neuropsychiatric systemic lupus erythematosus (NPSLE), especially active diffuse NPSLE syndromes, are some of the most difficult complications of the disease. For the evaluation and the diagnosis of central nervous system manifestations, including NPSLE, MRI is a very useful tool to detect the various abnormalities. However, the relationship between brain MRI findings and clinical variables has not yet been clarified in patients with diffuse NPSLE. OBJECTIVES: The aim of this study is to investigate the pathogenesis of diffuse NPSLE, by comparing various parameters such as serum autoantibodies and cytokines in cerebrospinal fluid (CSF) with abnormal findings revealed on brain MRIs in patients with diffuse NPSLE. METHODS: Fifty-three patients with diffuse NPSLE admitted to our University Hospital from 1992 to 2012 were exhaustively enrolled in this study. Their medical charts and brain MRI scans were reviewed. The relationship of MRI abnormalities with various parameters was analysed. RESULTS: As many as 25 of 53 patients (47.2%) had abnormal MRI findings. MRI findings improved after treatment in 10 of 17 patients for whom follow-up studies were available. MRI abnormalities were not correlated with age at the onset of diffuse NPSLE. However, the disease duration of SLE was significantly longer in patients with abnormal MRI findings (p=0.0009). MRI abnormalities were not significantly associated with serum autoantibodies. However, there were significant elevations of the CSF protein level (p=0.0106) and the CSF interleukin 6 level (p=0.0225) in patients with abnormal MRI findings. Patients with MRI abnormalities showed significantly higher overall mortality (p=0.0348). CONCLUSIONS: The results revealed that MRI abnormalities in diffuse NPSLE might be heterogeneous with regard to their reversibility. These data also indicate that patients with diffuse NPSLE and MRI abnormalities have more severe inflammation in the central nervous system related to the activity of diffuse NPSLE, as evidenced by poorer prognosis. BMJ Publishing Group 2014-11-03 /pmc/articles/PMC4225739/ /pubmed/25396069 http://dx.doi.org/10.1136/lupus-2014-000050 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Immunology and Inflammation
Arinuma, Yoshiyuki
Kikuchi, Hirotoshi
Wada, Tatsuhiko
Nagai, Tatsuo
Tanaka, Sumiaki
Oba, Hiroshi
Hirohata, Shunsei
Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title_full Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title_fullStr Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title_full_unstemmed Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title_short Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
title_sort brain mri in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225739/
https://www.ncbi.nlm.nih.gov/pubmed/25396069
http://dx.doi.org/10.1136/lupus-2014-000050
work_keys_str_mv AT arinumayoshiyuki brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT kikuchihirotoshi brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT wadatatsuhiko brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT nagaitatsuo brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT tanakasumiaki brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT obahiroshi brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus
AT hirohatashunsei brainmriinpatientswithdiffusepsychiatricneuropsychologicalsyndromesinsystemiclupuserythematosus